We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer (Spruce)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01829113
Recruitment Status : Completed
First Posted : April 11, 2013
Last Update Posted : August 22, 2017
Achieve Life Sciences
Information provided by (Responsible Party):
SCRI Development Innovations, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 19, 2017
  Study Completion Date : April 19, 2017